Lumos Diagnostics Holdings Ltd (ASX:LDX) Share Price

Company Profile

Business description
Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture, and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. The group is dedicated to providing contract research and development services, focusing on the innovation, development, manufacturing, and commercialization of point-of-care diagnostic solutions for both clinical and consumer applications. It generates maximum revenue from commercial services and solutions relating to POC diagnostic tests. The group has one operating segment, which is the provision of point-of-care diagnostics goods and services. The Company operates in two geographical regions, the United States and Australia and the majority of revenue is generated from the United States.
Contact
2724 Loker Avenue West
CarlsbadCA92010
USA
T: +1 855 586-6739
https://www.lumosdiagnostics.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 June 2026
Employees

Recommended

Allegations that the Chinese government told steel mills to stop buying from BHP shake markets.

Jon Mills, CFA | 08 October 2025

Charts from the Australian Dividend Outlook show the sectors where they are abundant.

Shani Jayamanne | 08 October 2025

Investors may be too pessimistic about this industry.

Jon Mills, CFA | 07 October 2025

Index	Last price	Change	% Change
All Ordinaries	9,276.60	19.90	-0.21%
CAC 40	8,092.44	32.31	0.40%
DAX 40	24,719.19	122.06	0.50%
Dow JONES (US)	46,601.78	1.20	-0.00%
FTSE 100	9,528.38	20.49	-0.21%
HKSE	26,752.59	76.87	-0.29%
NASDAQ	23,043.38	255.02	1.12%
Nikkei 225	48,580.44	845.45	1.77%
NZX 50 Index	13,570.86	2.38	0.02%
S&P 500	6,753.72	39.13	0.58%
S&P/ASX 200	8,969.80	25.20	-0.28%
SSE Composite Index	3,933.97	51.20	1.32%